首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1572540

白血球分離術市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Leukapheresis Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月22日 | 出版商:

Global Market Insights Inc. | 英文 195 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年白血球去除術市場價值約為 2.818 億美元，預計 2024 年至 2032 年複合年成長率為 12.7%。該過程包括抽取血液，透過機器過濾以分離白血球，然後將剩餘的血液成分（例如紅血球和血小板）返回給患者。

血癌發生率的上升是推動市場成長的主要因素。對有效治療的需求不斷增加，增加了對白血球去除術的需求，白血球去除術在通過去除異常白血球和改善患者預後來控制這些疾病方面發揮著至關重要的作用。此外，白血球分離設備和方法的創新，以及對免疫療法和細胞療法的日益關注，正在進一步支持市場。政府政策和措施也透過促進技術進步和改善獲得護理的機會來促進市場擴張。

整個白血球分離術產業根據產品、應用、最終用途和地區進行分類。

依產品分類，白血球分離術市場分為一次性用品和設備。預計到2032 年，包括白血球分離裝置和管道在內的一次性產品將達到5.026 億美元。的安全性和效率。

根據應用，市場分為治療和研究領域。治療領域到 2023 年將達到 1.555 億美元，包括血液學疾病和自體免疫疾病的治療。白血球分離術可以針對性地收集特定的白血球，從而提高免疫療法和幹細胞移植等治療的有效性。它還可以透過清除血液中的有害抗體和免疫複合物來幫助控制自體免疫疾病。

按最終用途分類，市場分為血液成分供應商和血液中心、學術和研究機構、製藥和生物技術公司以及醫院和輸血中心。到 2032 年，醫院和輸血中心預計將達到 2.977 億美元，其中白血球去除術能夠有效收集和分離白血球，用於各種治療，包括癌症免疫治療。

在技術進步和癌症治療需求不斷成長的推動下，美國白血球去除術市場預計將大幅成長，到 2032 年將達到 2.805 億美元。

產業生態系統分析
產業影響力
- 成長動力
  - 血癌及相關疾病病例不斷增加
  - 白血球分離裝置及其程序的創新
  - 研發激增，重點在於細胞療法和免疫療法
  - 政府的支持性措施和政策
- 產業陷阱與挑戰
  - 昂貴的白血球分離設備
  - 缺乏訓練有素的專業人員
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
定價分析
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
免洗用品
裝置
- 離心裝置
- 膜分離器
- 其他設備

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
治療性
- 血液學疾病
- 自體免疫疾病
- 其他治療應用
研究
- 癌症研究
- 免疫學研究
- 其他研究應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
血液成分提供者和血液中心
學術及研究機構
製藥和生物技術公司
醫院及輸血中心

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Asahi Kasei Corporation
Beijing ZKSK Technology Co., Ltd.
Baxter International Inc.
Cardinal Health, Inc.
Fresenius SE and Co. KGaA
Guangzhou DaJi Medical Science and Technology Co., Ltd.
Haemonetics Corporation
Macopharma
Medica SPA
Miltenyi Biotec
Mitra Industries Private Limited
Nikkiso Co. Ltd.
Puriblood Medical Co. Ltd.
SB-Kawasumi Laboratories, Inc.
Terumo BCT, Inc.

簡介目錄

Product Code: 10924

The Leukapheresis Market was valued at approximately USD 281.8 million in 2023 and is expected to grow at a CAGR of 12.7% from 2024 to 2032. Leukapheresis is a specialized medical procedure that extracts and collects white blood cells (leukocytes) from the bloodstream. The process involves drawing blood, filtering it through a machine to isolate the leukocytes, and then returning the remaining blood components, such as red blood cells and platelets, back to the patient.

The rising incidence of blood cancer is a major factor driving market growth. The increasing need for effective treatments has boosted the demand for leukapheresis, which plays a crucial role in managing these conditions by removing abnormal white blood cells and improving patient outcomes. Moreover, innovations in leukapheresis devices and methodologies, alongside a growing focus on immunotherapy and cell-based therapies, are further supporting the market. Government policies and initiatives also contribute to market expansion by fostering technological advancements and improving access to care.

The overall Leukapheresis industry is segregated based on Product, Application, End-use, and Region.

By product, the leukapheresis market is divided into disposables and devices. The disposable segment, including leukapheresis sets and tubing, is projected to reach USD 502.6 million by 2032. Disposables help reduce the risk of cross-contamination, eliminate the need for sterilization processes, and simplify procedures, enhancing both safety and efficiency in medical settings.

By application, the market is categorized into therapeutic and research segments. The therapeutic segment, which accounted for USD 155.5 million in 2023, includes treatments for hematology disorders and autoimmune diseases. Leukapheresis allows for the targeted collection of specific white blood cells, improving the effectiveness of treatments like immunotherapy and stem cell transplantation. It also aids in managing autoimmune conditions by removing harmful antibodies and immune complexes from the bloodstream.

By end-use, the market is segmented into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies, and hospital and transfusion centers. Hospitals and transfusion centers are expected to reach USD 297.7 million by 2032, with leukapheresis enabling efficient collection and separation of leukocytes for various treatments, including cancer immunotherapy.

The U.S. leukapheresis market is anticipated to grow significantly, reaching USD 280.5 million by 2032, driven by advancements in technology and the growing need for cancer treatments.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising cases of blood cancer and related disorders
  - 3.2.1.2 Innovations in leukapheresis devices and their procedures
  - 3.2.1.3 Surge in R&D focus on cell-based therapies and immunotherapy
  - 3.2.1.4 Supportive government initiatives and policies
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Expensive leukapheresis devices
  - 3.2.2.2 Shortage of trained professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Disposables
5.3 Devices
- 5.3.1 Centrifugal devices
- 5.3.2 Membrane separators
- 5.3.3 Other devices

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Therapeutic
- 6.2.1 Hematology disorders
- 6.2.2 Autoimmune diseases
- 6.2.3 Other therapeutic applications
6.3 Research
- 6.3.1 Cancer research
- 6.3.2 Immunology research
- 6.3.3 Other research applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Blood component providers and blood centers
7.3 Academic and research institutes
7.4 Pharmaceutical and biotechnology companies
7.5 Hospital and transfusion centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa